Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange Detected- Added a prominent operating-status notice and a link to updated operating details; updated version to v3.2.0. - Removed reference to v3.1.0.SummaryDifference10%

- Check35 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays revision v3.0.2, replacing v3.0.0. This appears to be a minor update/patch with no visible changes to core content.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's core content.SummaryDifference37%

- Check78 days agoChange DetectedThe web page has updated its version from v2.16.11 to v2.16.12, and the date has changed from June 25, 2025, to August 12, 2025.SummaryDifference1.0%

- Check85 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%

Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.